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Abstract Pdcd4 (Programmed Cell Death Protein 4) is a
novel eukaryotic tumour suppressor protein, which is
involved in the regulation of both transcription and transla-
tion (reviewed in Lankat-Buttgereit and Go ¨ke 2009). The
proteincontainstwointeractingMA-3domains(MA-3Mand
MA-3C), which are linked by a short semi-ﬂexible linker
region (Waters et al. 2007; Suzuki et al. 2008). The MA-3
domains are involved in mediating speciﬁc protein–protein
interactions with functional partners such as eIF4A (Yang




1H assignments for a construct
composedofthemiddleMA-3domainandsubsequentlinker
region (MA-3M) and backbone assignments for the entire
tandem MA-3 region of Pdcd4 (Pdcd4 MA-3M-C). Analysis
of the backbone chemical shift data obtained indicates that
Pdcd4 MA-3M contains eight helical regions corresponding
toover74%oftheproteinbackboneandthatPdcd4MA-3M-C
contains ﬁfteen helical regions (72%). Comparison of the
position of these helical regions with those observed in the
crystal structures suggests that the solution and crystal struc-
tures of both proteins are very similar.
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Biological context
The eukaryotic regulatory protein Pdcd4 (Programmed
Cell Death Protein 4) was initially discovered in a screen
for genes activated during apoptosis and later identiﬁed as
a tumour suppressor in studies of a mouse keratinocyte
model of tumour promotion. A number of subsequent
studies have also highlighted Pdcd4’s role as a tumour
suppressor, for example, Pdcd4 has been shown to suppress
tumour development in a mouse model of skin carcino-
genesis (reviewed in Lankat-Buttgereit and Go ¨ke 2009).
Pdcd4 has been shown to play critical roles in the regula-
tion of both transcription and translation, mediated via
speciﬁc protein–protein and perhaps protein-RNA interac-
tions (Bitomsky et al. 2004; Yang et al. 2003).
The 469 residue mouse Pdcd4 protein contains at least
threedomains,an N-terminalRNA-bindingregion (residues
1–157)andtwointeractingMA3domains(residues157–275
and 319–449), which are linked by a short semi ﬂexible
region (Waters et al. 2007; Suzuki et al. 2008). To date the
majority of the molecular and structural studies of Pdcd4
have focused on the interaction between the two MA-3
domains of Pdcd4 and the eukaryotic translation initiation
factor eIF4A, with complex formation resulting in the
inhibition of cap-dependent translation (Yang et al. 2003).
The structures of both the isolated C-terminal (MA-3C)
MA-3 domain, and a construct composed of the middle
MA-3 domain and subsequent linker region (MA-3M)o f
Pdcd4 have been solved and were shown to be composed of
three or four layers of atypical HEAT repeats respectively
(Waters et al. 2007; Suzuki et al. 2008). More recently, the
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has also been determined (Loh et al. 2009). To date only the
assignments for the Pdcd4 MA-3C have been deposited
(BMRB accession number 6900).
Here we report the determination of essentially complete
sequence-speciﬁc backbone and side chain assignments for
Pdcd4 MA-3M and backbone assignments for Pdcd4







of mouse Pdcd4 MA-3M (residues 157–318) and Pdcd4
MA-3M-C (residues 157–449) were prepared from pGex-6P-
2-based E. coli expression vectors essentially as described
previously for Pdcd4 MA-3C (Waters et al. 2006a), however,
for Pdcd4 MA-3M-C transformed cells protein expression
was induced for 20 h at 15C. In addition, the cleaved Pdcd4
constructs and GST were separated by a second round of
glutathione based afﬁnity chromatography prior to gel ﬁl-
tration. A
13C labelled Pdcd4 MA-3M sample which was
used for the
13C/
1H NOESY-HSQC experiment was pre-
pared as described above, but with the addition of non-
isotopically labelled aromatic amino acids to the minimal
media (His, Phe, Trp and Tyr at 50 mg/l).
NMR spectra of Pdcd4 MA-3M were acquired from
0.35 ml samples of 0.5–1.5 mM Pdcd4 MA-3M in a 25 mM
sodium phosphate, 100 mM sodium chloride, 0.5 mM DTT,
10 lM EDTA, 200 lM AEBSF and 0.02% (w/v) sodium
azide buffer at pH 6.5, containing 10% D2O/90% H2Oo r
100% D2O as appropriate. All NMR data were acquired at
25C on either 600 MHz Bruker Avance/DRX systems or
an 800 MHz Bruker Avance II spectrometer. The 2D and
3D spectra recorded to obtain sequence speciﬁc assign-
ments for Pdcd4 MA-3M were:
1H-
1H TOCSY with mixing
times of 35 and 55 ms,
1H-
1H NOESY with an NOE
mixing time of 100 ms;
15N/
1H HSQC; TOCSY-HSQC
with a mixing time of 55 ms; NOESY-HSQC with an NOE
mixing time of 100 ms;
13C/
1H HCCH-TOCSY with a
mixing time 19.6 ms,
13C/
1H HSQC-NOESY with an NOE




(CO)NH and HNCO (reviewed in Cavanagh et al. 2006).
Typical acquisition times in F1 and F2 for the 3D experi-
ments were 12–25 ms for
15N, 6.7–9.0 ms for
13C (35 ms
for HNCO experiments) and 15–22.5 ms for
1H, and with
an acquisition time of 55–70 ms in F3 (
1H). Typical
acquisition times in F1 for 2D experiments were 50 ms for
15N and 35 ms for
1H, with 80–100 ms in F2.
NMR spectra of Pdcd4 MA-3M-C were acquired from
0.35 ml samples of 0.15–0.50 mM Pdcd4 MA-3M-C in a
25 mM sodium phosphate, 100 mM sodium chloride,
2.5 mM DTT, 2.5 mM TCEP, 50 lM EDTA, 200 lM
AEBSF, and 0.02% (w/v) sodium azide buffer at pH 6.5,
containing 5% D2O/95% H2O. NMR data were acquired at
35C on an 800 MHz Bruker Avance II spectrometer. The
3D spectra recorded to obtain backbone assignments for
Pdcd4 MA-3M-C were:
15N/
1H NOESY-HSQC with an




HNCO, TROSY-HN(CO)CA and CBCA(CO)NH. Typical
acquisition times in F1 and F2 for the 3D experiments were
10–25 ms for
15N, 6.7–9.0 ms for
13C (22.5 ms for HNCO
experiments) and 16 ms for
1H, and with an acquisition
time of 60 ms in F3 (
1H).
The majority of the 3D spectra were collected over
approximately 72 h. The WATERGATE method was used
to suppress the water signal when required. The 3D NMR
data were processed using Topspin (Bruker Biospin Ltd)
with linear prediction used to extend the effective acqui-
sition times by up to twofold in F1 and F2. The spectra were
analysed using the Sparky package (T. D. Goddard and
D. G. Kneller, SPARKY 3, University of California, San
Francisco).
Sequence-speciﬁc backbone and side chain resonance
assignments were obtained for Pdcd4 MA-3M using the
approach described previously (Waters et al. 2006b). Ini-
tially, tentative sequence-speciﬁc backbone resonance
assignments (N, NH, Ca and CO) for Pdcd4 MA-3M-C were
obtained by transposing the assignments from the isolated
MA-3 domains (acquired at 25C) onto the triple resonance
spectra obtained for Pdcd4 MA-3M-C (acquired at 35C).
Ambiguities between the assignments obtained for the
individual MA-3 domains and Pdcd4 MA-3M-C, arising
fromdifferencesinthetemperatureatwhichthespectrawere
recorded and/or changes in the chemical environment of
residues located at the interface between the two MA-3
domains, were resolved by comparing the amide nitrogen/
proton and carbonyl chemical shifts of residues in HNCO
spectra recorded at a range of temperatures (25 and 35C for
theindividualMA-3domainsand25,30and35CforPdcd4
MA-3M-C). Finally, the inter-residue amide nitrogen/proton
toCaconnectivitiesobservedintripleresonancespectraand
the NH to NH NOEs identiﬁed in NOESY-HSQC spectra
were used to conﬁrm all the assignments made.
Fig. 1 Quality of the NMR spectra obtained for Pdcd4 MA-3M and
Pdcd4 MA-3M-C. Panel A shows an
15N/
1H HSQC spectrum of Pdcd4
MA-3M. The assignments of the signals from backbone amide groups
are indicated by residue type and number. The region between 6.7 and
7.8 ppm in
1H and 110.0 and 113.3 ppm in
15N contains, with the
exception of E210, S224, T229 and I273, signals from the sidechain
amide groups of the asparagine and glutamine residues. The signal
located at 10.0 ppm in
1H and 128.4 ppm in
15N ppm is from the
indolic-NH group of W315. The assignments obtained for overlapped
signals in the region between 7.7 and 8.4 ppm in
1H and 116.6 and
122.3 ppm in
15N are indicated in the enlarged region. Panel B shows
an
15N/
1HH S Q Cs p e c t r u mo fP d c d 4M A - 3 M-C and panel C a three
dimensional view of a
15N/
13C/
1HH N C Os p e c t r u mo fP d c d 4M A - 3 M-C
c
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Pdcd4 MA-3M gives rise to well-resolved spectra, as
illustrated by the
15N/
1H HSQC spectrum shown in Fig. 1a.
This allowed essentially complete backbone resonance
assignments to be made. Despite the relatively large size of
Pdcd4 MA-3M-C (293 residues) and consequent overlap of
signals in 2D
15N/
1H HSQC spectra, we were also able to
obtain comprehensive sequence-speciﬁc backbone reso-
nance assignments. The quality of the NMR spectra
obtained is illustrated by the HSQC and HNCO spectra
shown in Fig. 1b, c.
Backbone amide assignments were obtained for all
residues in Pdcd4 MA-3M except: D180, S214 and A291
(98.1%), for all Ca and Cb signals apart from M218 (Cb
only), C288 and Q290 (98.5%) and for all CO signals,
except for residues followed by a proline, and G179, A213,
T233, Q290 and G318 (93.2%). In the case of Ha and Hb
signals, assignments were obtained for all residues except:
P201, L207 (Hb3 only), R216, E217 (Hb2, Hb3), M218
(Hb3 only), K221 (Hb3 only), P258, L260, R267, C288,
Q290 and S317 (Hb3 only) (94.1%). For the remaining
non-exchangeable side chain signals (
13C and
1H) complete
assignments were obtained apart from: L188 ((Hd2)3),
L193 (Cc), K197 (He3), P201 (Cc,C d,H c2, Hc3, Hd2,
Hd3), L207 (Cc,H c), R216 (Cc,C d,H c2, Hc3, Hd2, Hd3),
P248 (Cc), P258 (Cc,C d,H c2, Hc3, Hd2, Hd3), L260 (Cc,
Cd1, Cd2, Hc,( H d1)3,( H d2)3), R267 (Cc,C d,H c2, Hc3,
Hd2, Hd3), V269 (Cc1), Q290 (Cc,H c2, Hc3) and W315
(Hf2, Hg2) (93.5%).
Backbone amide assignments were obtained for all
non-proline residues in Pdcd4 MA-3M-C except: D180,
S214, A291, G319, H326, V328, K329, E330, I331,
V356, H360, T397, D418, V419, S422 and S449 (94.0%),
for all Ca signals except: H326, V328, K329, E330,
V356, I415, L417, D418, V419, S422, P448 and S449
(95.9%), and for all CO signals except residues followed
by a proline, and G179, A213, T233, Q290, G318, N325,
L327, V328, K329, E330, E355, F359, I396, D414, L417,
D418, H421, P448 and S449 (89.8%). The comprehensive
15N,
13C and
1H resonance assignments obtained for
Pdcd4 MA-3M and Pdcd4 MA-3M-C have been deposited
Fig. 2 Location of the secondary structure elements in Pdcd4 MA-3M
and Pdcd4 MA-3M-C. Panel A shows the amino acid sequence of
Pdcd4 MA-3M. Highlighted in blue on the sequence are the positions
of the helical regions observed in the crystal structure of Pdcd4 MA-
3M (Suzuki et al. 2008: PDB code 2RG8). Indicated underneath the
sequence in purple and pink are the regions suggested to be helical by
the programmes TALOS (shown immediately below) and CSI
respectively. Residues for which no data could be obtained, due to
a lack of input chemical shifts, are highlighted in grey. Panel B shows
the amino acid sequence for the entire Pdcd4 MA-3M-C region.
Helical regions are indicated as in panel A. In this case, residues
highlighted in blue show the positions of the helical regions observed
in the crystal structure of Pdcd4 MA-3M-C (Loh et al. 2009: PDB code
3EIJ)
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Analysis of the backbone chemical shifts of Pdcd4
MA-3M, using the programme TALOS (Shen et al. 2009),
shows that the domain contains eight helical regions (res-
idues E161-H178, D180-L191, E195-E210, A213-L226,
T233-D253, P255-D271, N276-K283 and Q290-S305).
These regions are in close agreement with the position of
the secondary structure elements observed in the crystal
structure of Pdcd4 MA-3M, as shown in Fig. 2a (Suzuki
et al. 2008). Similarly, analysis of the backbone chemical
shifts of Pdcd4 MA-3M-C showed that there were 15 helical
regions (residues E161-H178, T181-L191, M196-E210,
A213-L226, T233-D253, P255-D271, N276-K283, V289-
S305, I331-L340, I344-E355, H360-E373, S378-S393,
I398-N416, Y423-A436 and K441-D445). These results are
also in close agreement with the position of the secondary
structure elements observed in the crystal structure of
Pdcd4 MA-3M-C, as shown in Fig. 2b (Loh et al. 2009).
The one exception is the absence of the N276-K283 helix
in the crystal structure, where this region is instead com-
posed of a series of bends and turns. However, it should be
noted that B-factors for this region are somewhat higher
than average. The NMR results reported here clearly
indicate that the solution and crystal structures of both
proteins are very similar.
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